These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection. Takata T, Miyazaki M, Futo M, Hara S, Shiotsuka S, Kamimura H, Yoshimura H, Matsunaga A, Nishida T, Ishikura H, Ishikawa T, Tamura K, Tsuji BT. Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753 [Abstract] [Full Text] [Related]
7. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. Sader HS, Jones RN, Rossi KL, Rybak MJ. J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978 [Abstract] [Full Text] [Related]
9. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia. Wi YM, Kim JM, Joo EJ, Ha YE, Kang CI, Ko KS, Chung DR, Song JH, Peck KR. Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565 [Abstract] [Full Text] [Related]
10. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan. Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR. J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366 [Abstract] [Full Text] [Related]
12. Impact of psm-mec in the mobile genetic element on the clinical characteristics and outcome of SCCmec-II methicillin-resistant Staphylococcus aureus bacteraemia in Japan. Aoyagi T, Kaito C, Sekimizu K, Omae Y, Saito Y, Mao H, Inomata S, Hatta M, Endo S, Kanamori H, Gu Y, Tokuda K, Yano H, Kitagawa M, Kaku M. Clin Microbiol Infect; 2014 Sep; 20(9):912-9. PubMed ID: 24476401 [Abstract] [Full Text] [Related]
17. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. Yoon YK, Kim JY, Park DW, Sohn JW, Kim MJ. J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036 [Abstract] [Full Text] [Related]
20. Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome. Kim T, Kim ES, Park SY, Sung H, Kim MN, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Chong YP, Kim YS. Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1473-1481. PubMed ID: 28337607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]